CMK SELECT
43 Route 46 East, Suite 705 Pine Brook, NJ 07058 USA
Rachel Phone: (973) 244-6060

FORGOT YOUR DETAILS?

+ Filters

Select one or more of the filter options below

CLOSE

Resource Center

The Rising Value of Medical Affairs – Engagement with External Stakeholders (KOLs, TLs, EEs)

AUTHOR: N. Borinshteyn

The ever-evolving relationship between the pharmaceutical industry and its key opinion leaders (KOLs) has been a hot topic for a while, and there are several…

CONTINUE READING

Launch Excellence: Is It Achievable?

AUTHOR: CMK SELECT

The numbers are dramatic: 50% of pharma launches fail to meet forecasts, with 25% widely missing the mark. If you’re in a pre-launch phase, with…

CONTINUE READING

Do Brands Have Value After Exclusivity?

AUTHOR: I. Deza

When a successful product is about to lose its exclusivity, and is facing incursions by generics or biosimilars, a pharmaceutical manufacturer sometimes decides to walk…

CONTINUE READING

Medical Events Compliance

AUTHOR: CMK SELECT

A major pharmaceutical company was in need of a review and approval process to help streamline the planning and execution of its external medical events.…

CONTINUE READING

Co-Promotion Optimization

AUTHOR: CMK SELECT

A notable pharmaceutical company had agreed to co-promote a drug and, in turn, was obligated to provide a list of contractual deliverables to the partner…

CONTINUE READING

The Continuously Increasing Value of Medical Affairs in Product Launches – Part II

AUTHOR: N. Borinshteyn

As we’ve already begun to look into in Part I of this two-part blog, Medical Affairs teams play a critical role in bringing new treatment…

CONTINUE READING

The Continuously Increasing Value of Medical Affairs in Product Launches – Part I

AUTHOR: N. Borinshteyn

Bringing each new pharmaceutical product to market is a complex and somewhat unique process led and executed by a cross-functional team who undertakes a number…

CONTINUE READING

Case for an IT-enabling Business Strategy for companies in the Life Sciences Industry

AUTHOR: D. Douglas

The major trends in the life sciences industry are profoundly affecting the way we all work – from conducting research to distributing products, and everything…

CONTINUE READING

Expense Report Compliance Audit

AUTHOR: CMK SELECT

A major pharmaceutical company engaged CMK Select to create a streamlined process for submitting, processing and approving monthly expense reports generated from their sales team’s…

CONTINUE READING

Clinical Data Standards

AUTHOR: CMK SELECT

Following the December 17, 2014, FDA binding guidance that all pharma studies starting after December 17, 2016, must conform to a set of FDA-sponsored standards,…

CONTINUE READING
Page 1 of 3123

LIKE OUR PAGE

FOLLOW US

GET LINKED IN

TOP